Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis.
Makinoya M, Miyatani K, Matsumi Y, Sakano Y, Shimizu S, Shishido Y, Hanaki T, Kihara K, Matsunaga T, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Hasegawa T, Saito H, Nakayama Y, Osaki M, Okada F, Fujiwara Y.
Makinoya M, et al. Among authors: kihara k.
Sci Rep. 2024 May 2;14(1):10075. doi: 10.1038/s41598-024-60967-x.
Sci Rep. 2024.
PMID: 38698201
Free PMC article.